Microbiotica
Cambridge, GB · Founded 2016 · 53 employees on LinkedIn · 3 known investors
Find your way into Microbiotica
14 people in our graph share verified history with the Microbiotica team — schools, employers, funds. One of them is your warm intro.
Raghd Rostomunlockedknows Trevor Lawley · together at Wellcome Trust Sanger Institute (overlapped)
knows the team · via Microbiotica
×10knows the team · via Wellcome Trust Sanger Institute
Microbiotica is a clinical-stage biopharmaceutical company developing precision live biotherapeutic products derived from the human microbiome for immuno-oncology and inflammatory bowel disease. The company uses a proprietary microbiome profiling platform based on clinical data to identify specific bacterial strains associated with patient benefit.
Founders & leadership
Microbiotica was founded in 2016 by Trevor Lawley.
TL
Trevor LawleyinCo-founder and CSOTrevor Lawley is a Senior Group Leader at the Wellcome Sanger Institute's Host-Microbiota Interactions Lab and co-founder and CSO of Microbiotica, a clinical-stage biopharmaceutical company he established in 2016 to develop live biotherapeutic products and microbiome-based diagnostics for autoimmune diseases and cancer. His research background spans microbiome science applied to infectious diseases, autoimmune conditions, and oncology, with publications in Nature and related journals.
Investors · 3
Competitors · 2
by search overlap
Resilient Biotics7 shared keywordsResilient Biotics uses microbiome genomics and data science to discover and develop non-antibiotic, precision microbial therapeutics derived from commensal microbial communities, aimed at preventing respiratory infectious diseases.
bio7 shared keywordsBIO is the world's largest advocacy association representing biotechnology companies and research institutions across the United States and 30+ other nations. The organization facilitates industry networking through events, conferences, and partnering software while providing cost-savings programs and advocacy services for member companies.
Companies competing with Microbiotica for the same Google search keywords, organic and paid, via search-intersection analysis.
Companies House · registry record
View on Companies House ↗- Registered name
- MICROBIOTICA LIMITED
- Company number
- 10269808
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 8 Jul 2016
- Registered office
- Chesterford Research Park, Little Chesterford, Cambridge, CB10 1XL
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Accounts
- last made up to 31 Dec 2025 · next due 30 Sept 2027
- Confirmation statement
- last made up to 7 Jul 2026 · next due 21 Jul 2027
Current officers · 7
- Carmine Daniel Circelli — director, appointed 12 Jan 2023
- Viet-Anh Anne Horgan — director, appointed 1 May 2025
- Trevor David Lawley — director, appointed 8 Jul 2016
- Mark Royston Quick — director, appointed 4 Mar 2022
- Johannes Gerardus Christiaan Petrus Schikan — director, appointed 1 Feb 2021
- Timothy Sharpington — director, appointed 1 Jan 2023
- Ip2ipo Services Limited — corporate director, appointed 15 Dec 2016
Source: Companies House public register · retrieved 7 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.
In the news
Frequently asked questions
- What does Microbiotica do?
- Microbiotica is a clinical-stage biopharmaceutical company developing precision live biotherapeutic products derived from the human microbiome for immuno-oncology and inflammatory bowel disease. The company uses a proprietary microbiome profiling platform based on clinical data to identify specific bacterial strains associated with patient benefit.
- Who founded Microbiotica?
- Microbiotica was founded by Trevor Lawley in 2016.
- Who are Microbiotica's investors?
- Microbiotica's investors include Cambridge Innovation Capital, Seventure Partners, DCVC (Data Collective).
- Where is Microbiotica headquartered?
- Microbiotica is headquartered in Cambridge, GB.